Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1783 of 6351
-
New hope for Tough-to-Treat colorectal cancer?
Disease control OngoingThis is an open-label clinical trial aimed at evaluating the safety and efficacy of the combination treatment of nelmastobart with capecitabine in patients diagnosed with metastatic or recurrent colorectal cancer.
Phase 1/2 • Sponsor: Korea University Anam Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:25 UTC
-
New IV fentanyl strategy aims to improve opioid addiction treatment
Disease control CompletedThe goal of this clinical trial is to test a treatment strategy for individuals with opioid use disorder (OUD) who use fentanyl. Participants will receive medically-administered doses of intravenous (IV) fentanyl at intervals until they are comfortable and do not have withdrawal …
Phase 4 • Sponsor: Pouya Azar • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug cocktail aims to boost CAR T-Cell success in lymphoma
Disease control Recruiting nowThis phase I trial tests the safety, side effects and best dose of CC-99282 with rituximab for the treatment of patients who have received chimeric antigen receptor (CAR) T cell therapy for non-Hodgkins lymphoma and in whom have had a sub-optimal response early on to CAR T-cell t…
Phase 1 • Sponsor: Nathan Denlinger • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Massive study probes why black patients fare worse in advanced cancer
Knowledge-focused Recruiting nowThis is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Zapping anxiety: head device shows promise for young adults with GAD
Symptom relief CompletedThe purpose of this research study is to study cranial electrotherapy stimulation (CES) to determine its effects on symptoms of anxiety in people with generalized anxiety disorder (GAD) between the ages of 18 - 21 years of age.
Sponsor: Electromedical Products International, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New shot could stop chronic hives when antihistamines fail
Disease control CompletedThe study is a Phase II, multicenter, randomized, double-blind study to evaluatethe efficacy and safety of LP-003 administered subcutaneously as an add-on therapy for the treatment of adult patients aged 18-75 who have been diagnosed with refractory CSU and who remain symptomatic…
Phase 2 • Sponsor: Longbio Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a Fat-Blocking pill tame deadly high blood fats?
Disease control Recruiting nowType I hyperlipoproteinemia (T1HLP, also known as familial chylomicronemia syndrome or FCS) is a rare diseasewhere the blood triglycerides (fats) are very high. It is caused by lack of certain enzymes and proteins in the bodythat are important in disposing circulating fats from b…
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Sound waves aim to calm uncontrollable movements in kids with cerebral palsy
Symptom relief Recruiting nowThe primary objective of the proposed study is to evaluate the safety of ExAblate Transcranial MRgFUS as a tool for creating bilateral or unilateral lesions in the globus pallidus (GPi) in patients with treatment-refractory secondary dystonia due to dyskinetic cerebral palsy
Sponsor: Children's National Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New anemia drug for dialysis patients enters final testing phase
Disease control Recruiting nowAn investigator-blinded, randomized, multicenter, active-controlled Phase III study for the treatment of anemia in patients with CKD on hemodialysis
Phase 3 • Sponsor: Genexine, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Hope for Friedreich's ataxia: new drug trial aims to slow disease progression
Disease control Recruiting nowAn open label study designed to evaluate the safety, PK, PD, and clinical effects of long-term daily administration of CTI-1601 enrolling adolescent and adult patients with FRDA who have participated in a prior clinical study of CTI-1601 as well as children (age 2 years and older…
Phase 2 • Sponsor: Larimar Therapeutics, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New Parkinson's pump shows promise in Real-World test
Disease control OngoingParkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. The purpose of this study is to evaluate…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Heart drug mavacamten under microscope: can it reshape damaged heart muscle?
Disease control OngoingThe purpose of this study is to evaluate the mavacamten impact on myocardial structure with cardiac magnetic resonance imaging (CMR) in adult participants with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) \[New York Heart Association (NYHA) Functional Class II or II…
Phase 4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New radiation approach aims to ease bone cancer pain
Symptom relief Recruiting nowTo compare increasing doses and different treatment schedules of stereotactic body radiation therapy (SBRT) against standard treatment scheduling.
Phase 3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New device may prevent muscle loss in ventilator patients
Disease control Recruiting nowThe study is a prospective, multi-center, randomized, controlled study using adaptive design to assess the evidence of safety and performance of the STIMIT Activator 1 System in the treatment of patients who have been mechanically ventilated for up to 7 days and are predicted to …
Sponsor: Stimit AG • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
VR games show promise for stroke recovery in small trial
Symptom relief CompletedThis prospective single-blind randomized controlled trial enrolled 43 hemiplegic patients hospitalized in the neurological rehabilitation unit of the University of Health Sciences Ankara Etlik City Hospital. Participants were randomly assigned to a virtual reality (VR) group (n =…
Sponsor: Gaziantep City Hospital • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New malaria combo shows promise in clearing parasite
Disease control CompletedThis was Cohort B2 of the Platform study (NCT05750628) to evaluate the efficacy and safety of Cipargamin + KLU156 in participants with uncomplicated Plasmodium falciparum malaria.
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could vitamin B3 save sight in rare optic nerve disease?
Disease control OngoingDominant Optic Atrophy (hereafter known as DOA) is a neurodegenerative pathology of the optic nerve inducing progressive loss of central visual field and visual acuity. There is currently no proven treatment for this disease. The metabolomics work of Pascal Reynier's team reveale…
Phase 2/3 • Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Robot surgeons take on gallbladder cancer in global trial
Disease control Recruiting nowThe Robocop trial is an international multi-centre, single blinded, randomized controlled superiority trial conducted in centres experienced in robotic-assisted liver surgery. Eligible patients for radical cholecystectomy will be randomized in a 1:1 ratio to undergo robotic-assis…
Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:27 UTC
-
New drug combo targets Hard-to-Treat lymphomas
Disease control Recruiting nowThis study is designed to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary efficacy following oral administration of AZD3470 as a monotherapy, and in combination with other anticancer agents in participants with haematologic malignancies.
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Double-Duty mRNA vaccine targets RSV and hMPV in early trial
Vaccine CompletedThe purpose of this study is to evaluate the safety and immunogenicity an investigational messenger ribonucleic acid (mRN)A vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) and/or human metapneumovirus (hMPV) in olde…
Phase 1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 26, 2026 16:03 UTC